ADPedKD: A Global Online Platform on the Management of Children With ADPKD

[en] Background: Autosomal dominant polycystic kidney disease (ADPKD) is the most common monogenic cause of renal failure. For several decades, ADPKD was regarded as an adult-onset disease. In the past decade, it has become more widely appreciated that the disease course begins in childhood. However, evidence-based guidelines on how to manage and approach children diagnosed with or at risk of ADPKD are lacking. Also, scoring systems to stratify patients into risk categories have been established only for adults. Overall, there are insufficient data on the clinical course during childhood. We therefore initiated the global ADPedKD project to establish a large international pediatric ADPKD cohort for deep characterization. Methods: Global ADPedKD is an international multicenter observational study focusing on childhood-diagnosed ADPKD. This collaborative project is based on interoperable Web-based databases, comprising 7 regional and independent but uniformly organized chapters, namely Africa, Asia, Australia, Europe, North America, South America, and the United Kingdom. In the database, a detailed basic data questionnaire, including genetics, is used in combination with data entry from follow-up visits, to provide both retrospective and prospective longitudinal data on clinical, radiologic, and laboratory findings, as well as therapeutic interventions. Discussion: The global ADPedKD initiative aims to characterize in detail the most extensive international pediatric ADPKD cohort reported to date, providing evidence for the development of unified diagnostic, follow-up, and treatment recommendations regarding modifiable disease factors. Moreover, this registry will serve as a platform for the development of clinical and/or biochemical markers predicting the risk of early and progressive disease. © 2019 International Society of Nephrology

Disciplines :

Urology & nephrology
Pediatrics

Author, co-author :

De Rechter, Stéphanie; Department of Pediatric Nephrology, University Hospitals Leuven, Leuven, Belgium, PKD Research Group, Department of Development and Regeneration, KU Leuven, Leuven, Leuven, Belgium

Bockenhauer, Detlef; UCL Centre for Nephrology, London, United Kingdom, Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom

Guay-Woodford, Lisa M.; Center for Translational Science, Children's National Health System, Washington, DC, United States

Liu, Isaac; Khoo Teck Puat–National University Children's Medical Institute, National University Health System, Singapore, Singapore

Mallett, Andrew J.; Kidney Health Service and Conjoint Renal Research Laboratory, Royal Brisbane and Women's Hospital, Brisbane, Australia, Faculty of Medicine and Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia, The KidGen Collaborative and Australian Genomics Health Alliance, Melbourne, Australia

Soliman, Neveen A.; Department of Pediatrics, Centre of Pediatric Nephrology and Transplantation, Kasr Al Ainy School of Medicine, Cairo University, Cairo, Egypt

Sylvestre, Lucimary C.; Hospital Pequeno Príncipe, Curitiba, Brazil

Schaefer, Franz; Division of Pediatric Nephrology, Centre for Pediatrics and Adolescent Medicine, Heidelberg University Medical Centre, Heidelberg, Germany

Liebau, Max C.; Department of Pediatrics and Center for Molecular Medicine, University Hospital of Cologne, Cologne, Germany

Mekahli, Djalila; Department of Pediatric Nephrology, University Hospitals Leuven, Leuven, Belgium, PKD Research Group, Department of Development and Regeneration, KU Leuven, Leuven, Leuven, Belgium

More authors (141 more)

Language :

English

Title :

ADPedKD: A Global Online Platform on the Management of Children With ADPKD

Publication date :

29 May 2019

Journal title :

Kidney International Reports

eISSN :

2468-0249

Publisher :

Elsevier Inc

Volume :

Issue :

Pages :

1271-1284

Peer reviewed :

Peer Reviewed verified by ORBi

Funders :

Marmara ÜniversitesiChung Hua University, CHU: SerbiaUnited Arab Emirates University, UAEUMedizinischen Hochschule Hannover, MHHCity, University of London, CityApplied Scientific Research Fund, ASRF: 11M5214NNational Institutes of Health, NIHNational Institutes of Health, NIHInstitute of Clinical and Translational Sciences, ICTSAmerican Society of Pediatric Nephrology, ASPNNational Center for Advancing Translational Sciences, NCATS: UL1TR001876American Society of Pediatric Nephrology, ASPNNational Institute of Diabetes and Digestive and Kidney Diseases, NIDDK: P30 DK074038

Available on ORBi :

since 28 January 2020

Statistics

Number of views

87 (10 by ULiège)

Number of downloads

38 (7 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Torres, V.E., Harris, P.C., Pirson, Y., Autosomal dominant polycystic kidney disease. Lancet 369 (2007), 1287–1301.
Cornec-Le Gall, E., Olson, R.J., Besse, W., et al. Monoallelic mutations to DNAJB11 cause atypical autosomal dominant polycystic kidney disease. Am J Hum Genet 102:5 (2018), 832–844.
Porath, B., Gainullin, V.G., Cornec-Le Gall, E., et al. Mutations in GANAB, encoding the glucosidase IIalpha subunit, cause autosomal-dominant polycystic kidney and liver disease. Am J Hum Genet 98:6 (2016), 1193–1207.
Ong, A.C., Devuyst, O., Knebelmann, B., Walz, G., Autosomal dominant polycystic kidney disease: the changing face of clinical management. Lancet 385 (2015), 1993–2002.
Cornec-Le Gall, E., Audrézet, M.P., Chenn, J.M., et al. Type of PKD1 mutation influences renal outcome in ADPKD. J Am Soc Nephrol 24 (2013), 1006–1013.
Torres, V.E., Chapman, A.B., Devuyst, O., et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med 367 (2012), 2407–2418.
Schrier, R.W., Abebe, K.Z., Perrone, R.D., et al. Blood pressure in early autosomal dominant polycystic kidney disease. N Engl J Med 371 (2014), 2255–2266.
Torres, V.E., Abebe, K.Z., Chapman, A.B., et al. Angiotensin blockade in late autosomal dominant polycystic kidney disease. N Engl J Med 371 (2014), 2267–2276.
Ecder, T., Schrier, R.W., Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease. Nat Rev Nephrol 5 (2009), 221–228.
Mikolajczyk, A.E., Te, H.S., Chapman, A.B., Gastrointestinal manifestations of autosomal-dominant polycystic kidney disease. Clin Gastroenterol Hepatol 15 (2017), 17–24.
Grantham, J.J., Rationale for early treatment of polycystic kidney disease. Pediatr Nephrol 30 (2014), 1053–1062.
Cadnapaphornchai, M.A., Masoumi, A., Strain, J.D., et al. Magnetic resonance imaging of kidney and cyst volume in children with ADPKD. Clin J Am Soc Nephrol 6 (2011), 369–376.
Cadnapaphornchai, M.A., McFann, K., Strain, J.D., et al. Increased left ventricular mass in children with autosomal dominant polycystic kidney disease and borderline hypertension. Kidney Int 74 (2008), 1192–1196.
Massella, L., Mekahli, D., Paripovic, D., et al. Prevalence of hypertension in children with early-stage ADPKD. Clin J Am Soc Nephrol 13 (2018), 874–883.
Mekahli, D., Woolf, A.S., Bockenhauer, D., Similar renal outcomes in children with ADPKD diagnosed by screening or presenting with symptoms. Pediatr Nephrol 25 (2010), 2275–2282.
Selistre, L., de Souza, V., Ranchin, B., et al. Early renal abnormalities in children with postnatally diagnosed autosomal dominant polycystic kidney disease. Pediatr Nephrol 27 (2012), 1589–1593.
Sharp, C., Johnson, A., Gabow, P., Factors relating to urinary protein excretion in children with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 9 (1998), 1908–1914.
Rizk, D., Chapman, A., Treatment of autosomal dominant polycystic kidney disease (ADPKD): the new horizon for children with ADPKD. Pediatr Nephrol 23 (2008), 1029–1036.
Cadnapaphornchai, M.A., Clinical trials in pediatric autosomal dominant polycystic kidney disease. Front Pediatr, 5, 2017, 53.
De Rechter, S., Breysem, L., Mekahli, D., Is autosomal dominant polycystic kidney disease becoming a pediatric disorder?. Front Pediatr, 5, 2017, 272.
Harris, T., Is it ethical to test apparently “healthy” children for autosomal dominant polycystic kidney disease and risk medicalizing thousands?. Front Pediatr, 5, 2017, 291.
De Rechter, S., Kringen, J., Janssens, P., et al. Clinicians' attitude towards family planning and timing of diagnosis in autosomal dominant polycystic kidney disease. PLoS One, 12, 2017, e0185779.
Chapman, A.B., Devuyst, O., Eckardt, K.U., et al. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 88 (2015), 17–27.
European ADPKD Forum. Translating science into policy to improve ADPKD care. Available at: https://pkdinternational.org/component/content/article/2-uncategorised/3-european-adpkd-forum-report-launched. Published January 29, 2015. Accessed July 6, 2019.
Co-chairs, E.A.F., Harris, T., Sandford, R., et al. European ADPKD Forum multidisciplinary position statement on autosomal dominant polycystic kidney disease care: European ADPKD Forum and Multispecialist Roundtable participants. Nephrol Dial Transplant 33 (2018), 563–573.
Rangan, G.K., Savige, J., Introduction to the KHA-CARI guidelines on ADPKD. Semin Nephrol 35 (2015), 521–523.
Gimpel C, Bergmann C, Bockenhauer D, et al. International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people [e-pub ahead of print]. Nat Rev Nephrol. https://doi.org/10.1038/s41581-019-0155-2. Published May 22, 2019. Accessed July 2, 2019.
Pei, Y., Obaji, J., Dupuis, A., et al. Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol 20 (2009), 205–212.
Willey, C.J., Blais, J.D., Hall, A.K., et al. Prevalence of autosomal dominant polycystic kidney disease in the European Union. Nephrol Dial Transplant 32 (2017), 1356–1363.
Yersin, C., Bovet, P., Wauters, J.P., et al. Frequency and impact of autosomal dominant polycystic kidney disease in the Seychelles (Indian Ocean). Nephrol Dial Transplant 12 (1997), 2069–2074.
Iglesias, C.G., Torres, V.E., Offord, K.P., et al. Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935–1980. Am J Kidney Dis 2 (1983), 630–639.
Higashihara, E., Nutahara, K., Kojima, M., et al. Prevalence and renal prognosis of diagnosed autosomal dominant polycystic kidney disease in Japan. Nephron 80 (1998), 421–427.
Grantham, J.J., Torres, V.E., Chapman, A.B., et al. Volume progression in polycystic kidney disease. N Engl J Med 354 (2006), 2122–2130.
Gabow, P.A., Duley, I., Johnson, A.M., Clinical profiles of gross hematuria in autosomal dominant polycystic kidney disease. Am J Kidney Dis 20 (1992), 140–143.
Chapman, A.B., Johnson, A.M., Gabow, P.A., Schrier, R.W., Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 5 (1994), 1349–1354.
Martinez-Vea, A., Gutierrez, C., Bardají, A., et al. Microalbuminuria in normotensive patients with autosomal-dominant polycystic kidney disease. Scand J Urol Nephrol 32 (1998), 356–359.
Idrizi, A., Barbullushi, M., Koroshi, A., et al. Urinary tract infections in polycystic kidney disease. Med Arh 65 (2011), 213–215.
D'Agnolo, H.M.A., Casteleijn, N.F., Gevers, T.J.G., et al. The association of combined total kidney and liver volume with pain and gastrointestinal symptoms in patients with later stage autosomal dominant polycystic kidney disease. Am J Nephrol 46 (2017), 239–248.
Fick, G.M., Duley, I.T., Johnson, A.M., et al. The spectrum of autosomal dominant polycystic kidney disease in children. J Am Soc Nephrol 4 (1994), 1654–1660.
Dimitrakov, D., Simeonov, S., Studies on nephrolithiasis in patients with autosomal dominant polycystic kidney disease. Folia Med (Plovdiv) 36 (1994), 27–30.
Gabow, P.A., Kaehny, W.D., Johnson, A.M., et al. The clinical utility of renal concentrating capacity in polycystic kidney disease. Kidney Int 35 (1989), 675–680.
Reddy, B.V., Chapman, A.B., The spectrum of autosomal dominant polycystic kidney disease in children and adolescents. Pediatr Nephrol 32 (2017), 31–42.
Firinci, F., Soylu, A., Kasap Demir, B., et al. An 11-year-old child with autosomal dominant polycystic kidney disease who presented with nephrolithiasis. Case Rep Med, 2012, 2012, 428749.
Seeman, T., Dusek, J., Vondrák, K., et al. Renal concentrating capacity is linked to blood pressure in children with autosomal dominant polycystic kidney disease. Physiol Res 53 (2004), 629–634.
Sallee, M., Rafat, C., Zahar, J.R., et al. Cyst infections in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 4 (2009), 1183–1189.
Helal, I., Reed, B., McFann, K., et al. Glomerular hyperfiltration and renal progression in children with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 6 (2011), 2439–2443.
Bae, K.T., Zhu, F., Chapman, A.B., et al. Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort. Clin J Am Soc Nephrol 1 (2006), 64–69.
Dell, K.M., The spectrum of polycystic kidney disease in children. Adv Chronic Kidney Dis 18 (2011), 339–347.
Seeman, T., Dusek, J., Vondrichová, H., et al. Ambulatory blood pressure correlates with renal volume and number of renal cysts in children with autosomal dominant polycystic kidney disease. Blood Press Monit 8 (2003), 107–110.
Marlais, M., Cuthell, O., Langan, D., et al. Hypertension in autosomal dominant polycystic kidney disease: a meta-analysis. Arch Dis Child 101 (2016), 1142–1147.
Chapman, A.B., Johnson, A.M., Rainguet, S., et al. Left ventricular hypertrophy in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 8 (1997), 1292–1297.
Ivy, D.D., Shaffer, E.M., Johnson, A.M., et al. Cardiovascular abnormalities in children with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 5 (1995), 2032–2036.
Zeier, M., Geberth, S., Schmidt, K.G., et al. Elevated blood pressure profile and left ventricular mass in children and young adults with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 3 (1993), 1451–1457.
Xu, H.W., Yu, S.Q., Mei, C.L., Li, M.H., Screening for intracranial aneurysm in 355 patients with autosomal-dominant polycystic kidney disease. Stroke 42 (2011), 204–206.
Mikolajczyk, A.E., Te, H.S., Chapman, A.B., Gastrointestinal manifestations of autosomal dominant polycystic kidney disease. Clin Gastroenterol Hepatol 15 (2017), 17–24.
Kubo, S., Nakajima, M., Fukuda, K., et al. A 4-year-old girl with autosomal dominant polycystic kidney disease complicated by a ruptured intracranial aneurysm. Eur J Pediatr 163 (2004), 675–677.
Thong, K.M., Ong, A.C., Sudden death due to subarachnoid haemorrhage in an infant with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 29:Suppl 4 (2014), iv121–iv123.
Food and Drug Administration. Available at: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm458483.pdf Accessed September 2016.
Woon, C., Bielinski-Bradbury, A., O'Reilly, K., Robinson, P., A systematic review of the predictors of disease progression in patients with autosomal dominant polycystic kidney disease. BMC Nephrol, 16, 2015, 140.
Nowak, K.L., Cadnapaphornchai, M.A., Chonchol, M.B., et al. Long-term outcomes in patients with very-early onset autosomal dominant polycystic kidney disease. Am J Nephrol 44 (2016), 171–178.
Fick, G.M., Johnson, A.M., Strain, J.D., et al. Characteristics of very early onset autosomal dominant polycystic kidney disease. J Am Soc Nephrol 3 (1993), 1863–1870.
Sedman, A., Bell, P., Manco-Johnson, M., et al. Autosomal dominant polycystic kidney disease in childhood: a longitudinal study. Kidney Int 31 (1987), 1000–1005.
Shamshirsaz, A.A., Reza Bekheirnia, M., Kamgar, M., et al. Autosomal dominant polycystic kidney disease in infancy and childhood: progression and outcome. Kidney Int 68 (2005), 2218–2224.
Seeman, T., Sikut, M., Konrad, M., et al. Blood pressure and renal function in autosomal dominant polycystic kidney disease. Pediatr Nephrol 11 (1997), 592–596.
Audrézet, M.P., Corbiere, C., Lebbah, S., et al. Comprehensive PKD1 and PKD2 mutation analysis in prenatal autosomal dominant polycystic kidney disease. J Am Soc Nephrol 27 (2016), 722–729.
Fencl, F., Janda, J., Bláhová, K., et al. Genotype-phenotype correlation in children with autosomal dominant polycystic kidney disease. Pediatr Nephrol 24 (2009), 983–989.
Cornec-Le Gall, E., Audrézet, M.P., Rousseau, A., et al. The PROPKD score: a new algorithm to predict renal survival in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 27 (2015), 942–951.
Irazabal, M.V., Rangel, L.J., Bergstralh, E.J., et al. Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials. J Am Soc Nephrol 26 (2015), 160–172.
McEwan, P., Bennett Wilton, H., Ong, A.C.M., et al. A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model. BMC Nephrol, 19, 2018, 37.
Gansevoort, R.T., Arici, M., Benzing, T., et al. Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice. Nephrol Dial Transplant 31 (2016), 337–348.
Cadnapaphornchai, M.A., McFann, K., Strain, J.D., et al. Prospective change in renal volume and function in children with ADPKD. Clin J Am Soc Nephrol 4 (2009), 820–829.
Fick-Brosnahan, G.M., Tran, Z.V., Johnson, A.M., et al. Progression of autosomal-dominant polycystic kidney disease in children. Kidney Int 59 (2001), 1654–1662.
Alam, A., Dahl, N.K., Lipschutz, J.H., et al. Total kidney volume in autosomal dominant polycystic kidney disease: a biomarker of disease progression and therapeutic efficacy. Am J Kidney Dis 66 (2015), 564–576.
Reddy, B.V., Chapman, A.B., The spectrum of autosomal dominant polycystic kidney disease in children and adolescents. Pediatr Nephrol 32 (2017), 31–42.
European Commission, 2018 reform of EU data protection rules. Available at: https://ec.europa.eu/commission/priorities/justice-and-fundamental-rights/data-protection/2018-reform-eu-data-protection-rules_en. (Accessed 6 July 2019)
de Onis, M., Update on the implementation of the WHO child growth standards. World Rev Nutr Diet 106 (2013), 75–82.
Alzarka, B., Morizono, H., Bollman, J.W., et al. Design and implementation of the Hepatorenal Fibrocystic Disease Core Center Clinical Database: a centralized resource for characterizing autosomal recessive polycystic kidney disease and other hepatorenal fibrocystic diseases. Front Pediatr, 5, 2017, 80.
Tanner, J.M., Physical growth and development. Forfar, J.O., Arnell, C.C., (eds.) Textbook of Pediatrics, 2nd ed., 1978, Churchill Livingstone, Edinburgh, 249–303.
Gliklich, R., Dreyer, N., Leavy, M., (eds.) Registries for Evaluating Patient Outcomes: A User's Guide. Third edition. Two volumes. (Prepared by the Outcome DEcIDE Center [Outcome Sciences, Inc., a Quintiles company] under Contract No. 290 2005 00351 TO7.) AHRQ Publication No. 13(14)-EHC111, April 2014, Agency for Healthcare Research and Quality, Rockville, MD Available at: http://www.effectivehealthcare.ahrq.gov/registries-guide-3.cfm. (Accessed 6 July 2019)
Soliman, N.A., Nabhan, M.M., Bazaraa, H.M., et al. Clinical and ultrasonographical characterization of childhood cystic kidney diseases in Egypt. Ren Fail 36 (2014), 694–700.
Brosnahan, G.M., Abebe, K.Z., Moore, C.G., et al. Determinants of progression in early autosomal dominant polycystic kidney disease: is it blood pressure or renin-angiotensin-aldosterone-system blockade?. Curr Hypertens Rev 14 (2018), 39–47.
Swift, O., Vilar, E., Rahman, B., et al. Attitudes in patients with autosomal dominant polycystic kidney disease toward prenatal diagnosis and preimplantation genetic diagnosis. Genet Test Mol Biomarkers 20 (2016), 741–746.